Stock Ratings / Health Care / BFLY / insiders

PHG (58) GEHC (65) NNOX (32) VIR (31) ⌘ Pro Terminal →

Butterfly Network Inc. (Class A) (BFLY) Insider, 13F Hedge Fund & Politician Buy/Sell Thermometer

$7.51 -3.84% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $7.44

Butterfly Network Inc. (Class A) (BFLY) carries a Roarable Rating of D- (Sell) with 38/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record Warning: Scores below 50 (38/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows →

ROARABLE D- • RED ALERT Cap $2.00B

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $7.44 (-0.88%)🧬 Dilution Drag (+2.48% YoY Shares)⚙️ Cash Engine: 10/20 (D) • 0% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record Warning: Scores below 50 (38/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows (-7.8% avg 90D alpha vs SPY • 29.0% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERRED ALERT • D-

2-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw E · Rk D

Each axis scored 0–20

12M PRICE TARGET CONE-9.1% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for BFLY)Realized 20D OHLCV Swing Band: ±12.5%

Deterministic 5-Pillar Attribution (38/100 Composite)

🔍 WHY BFLY SCORES 38/100 (D-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: SEC 10-K Forensic Risk+14/20 pts (37% of score)

Altman Z-Score 7.89 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 4/9

▲ #2 Bullish Driver: Cash Engine Quality+10/20 pts (26% of score)

SEC XBRL FY 2025 (10-K): 0% FCF Margin ($0 FCF) & 46.9% Gross Margin

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution4/20 pts (-16 pt drag)

Dilution Drag (+2.48% YoY Shares) & executive Form 4 sales trim 16 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade D$8.25-12.1% Next Q

Q2 (-2Q)

Grade D$7.25-6.8% Next Q

Q3 (-1Q)

Grade D$6.76+11.1% Next Q

Current

Grade D-$7.51-7.8% Hist 90D α

Trajectory: D (46) → D- (38)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a BFLY Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While BFLY currently carries a cautious 38/100 (D-) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Health Care with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($8.07) and Max Pain ($7.89) forces dealer call-delta covering toward $10.72.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Dilution Drag (+2.48% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $BFLY• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “BFLY Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 38%NO 62%Trade / Inspect Odds →

SEC FORM 4 × 13F HEDGE FUNDS × CONGRESSIONAL STOCK ACT

BFLY Smart-Money Thermometer: NET EXECUTIVE TRIMMING / PROFIT-TAKING

Explore All 13F & Congress Whales →

▲ Disclosed Buys: 0 ($0)▼ Disclosed Sales: 0 ($0)

Wide-Open SEC Form 4, 13F & Congressional Disclosure Ledger (BFLY)

No recent open-market Form 4 cluster sales or emergency dumps flagged on BFLY. Visit the Global 13F & Congressional Whale Ledger for cross-market smart-money filings.

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring BFLY)

✓Walkthrough of BFLY's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

BFLY // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +56.78%▼ SUPPORT BREAKDOWN

2026-10-30O $7.18H $7.51L $6.29C $7.51VOL 7.48M

RES: $10.28SUP: $7.57SMA50: $8.07SMA200: $6.04

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

BFLY Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 BFLY Butterfly Map → + Track BFLY →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. +19.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on BFLY today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for BFLY. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for BFLY today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (BFLY)

Health Care Rank #698 of 1016 ⚔️ PHG vs BFLY Full Matrix →

1. Head-to-Head Health Care Peer Comparison (BFLY vs. PHG, GEHC, NNOX, VIR)

Industry: Medical Electronics (4 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Butterfly Network Inc. (Class A) (BFLY) ranks #698 by composite RQD confidence (38/100, grade D-) and #265 by equity capitalization ($2.00B). Within this direct 5-issuer industry benchmark cohort, GEHC leads on earnings valuation at 16.6x trailing P/E, while GEHC leads on capital efficiency and profitability with 14.2% ROIC and 40.0% gross margin. GEHC currently holds the highest overall quantitative score in the immediate peer group at 65/100 (C) compared with BFLY at 38/100 (D-).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
BFLY ACTIVE Butterfly Network Inc. (Class A)	D-	38/100	—	46.9%	-35.0%	-3.84%	$2.00B	Benchmark Subject
PHG Koninklijke Philips N.V. NY Registry Shares	D+	58/100	32.8x	—	9.9%	+0.33%	$26.66B	/phg-vs-bfly →
GEHC GE HealthCare Technologies Inc.	C	65/100	16.6x	40.0%	14.2%	+0.79%	$34.55B	/gehc-vs-bfly →
NNOX NANO-X IMAGING LTD	E	32/100	—	-30.0%	-35.0%	-4.82%	$24.0M	/nnox-vs-bfly →
VIR Vir Biotechnology Inc.	E	31/100	—	96.0%	-35.0%	-1.51%	$2.01B	/vir-vs-bfly →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001804176

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Butterfly Network Inc. (Class A) (BFLY) reported GAAP revenue of $97.6M (+19.0% vs. FY2024 revenue of $82.1M , and +48.1% cumulative change since FY2023) , GAAP net income of -$77.1M, operating cash flow of -$12.7M, and free cash flow of -$16.0M (+63.9% YoY). On the balance sheet, BFLY closed FY2025 with $296.5M in total assets against $0 in total debt (Altman Z-Score: 7.89, Piotroski F-Score: 4/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$97.6M	-$77.1M	-$12.7M	-$16.0M	$296.5M	—
FY2024 (FY)	2024-12-31	$82.1M	-$72.5M	-$41.7M	-$44.4M	$256.1M	—
FY2023 (FY)	2023-12-31	$65.9M	-$133.7M	-$98.8M	-$98.8M	—	—

3. BFLY Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is BFLY stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Butterfly Network Inc. (Class A) (NYSE: BFLY) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 38/100 at a spot price of $7.51 (-3.84% 1D, market cap $2.00B). Pillar breakdown: Fundamental Cash Engine 10/20, Institutional 13F & Options Flow 5/20, Executive Insider Alignment 14/20, FRED Macro Regime Fit 6/20, and SEC Balance-Sheet Forensics 3/20. Across 1016 tracked Health Care issuers, BFLY ranks #698 in composite RQD confidence.

How does BFLY compare to PHG and GEHC in the Health Care sector?

Within the Health Care sector (Medical Electronics), BFLY carries a Roarable D- (38/100 RQD), trailing P/E of N/A, gross margin of 46.9%, and ROIC of -35.0%. By comparison, PHG (Koninklijke Philips N.V. NY Registry Shares) holds a D+ grade (58/100 RQD, P/E 32.8x, ROIC 9.9%, cap $26.66B) and GEHC (GE HealthCare Technologies Inc.) posts a C grade (65/100 RQD, P/E 16.6x, ROIC 14.2%, cap $34.55B). Among the 5-stock peer group, GEHC leads on earnings multiple (16.6x) while GEHC leads on capital efficiency (14.2% ROIC).

What are the biggest fundamental strengths and SEC risk factors for BFLY?

Per BFLY's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001804176), Butterfly Network Inc. (Class A) generated $97.6M in revenue (+19.0% YoY), -$77.1M in net income, and -$16.0M in free cash flow against $296.5M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is BFLY trading relative to its 50-day, 200-day, and 52-week technical levels?

BFLY last traded at $7.51 (-3.84% on volume of 5,904,774 shares), positioning the stock -6.94% below its 50-day simple moving average ($8.07) and +24.34% above its 200-day simple moving average ($6.04). Across its 52-week range of $1.90 to $10.21, BFLY sits at the 67.5% percentile with a 14-day RSI of 37.5 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($6.57 to $8.45).

BFLY Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Are BFLY insiders and hedge funds buying or selling?

Roarable's SEC Form 4 and 13F Whale Thermometer currently classifies BFLY leadership and institutional positioning as: NET EXECUTIVE TRIMMING / PROFIT-TAKING.

Direct Sub-Reports: BFLY RQD Cockpit BFLY 12M Forecast BFLY Earnings & Move BFLY Dividends & DRIP BFLY Insiders & 13F BFLY Whale Options BFLY Profit Sankey BFLY News & Why